Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $1.72

Biomerica, Inc. (NASDAQ:BMRA)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.72 and traded as low as $1.14. Biomerica shares last traded at $1.15, with a volume of 15,055 shares traded.

Biomerica Stock Down 1.7 %

The company has a market capitalization of $19.33 million, a price-to-earnings ratio of -2.13 and a beta of -0.62. The company has a 50 day simple moving average of $1.35 and a 200 day simple moving average of $1.72.

Institutional Investors Weigh In On Biomerica

A number of large investors have recently modified their holdings of BMRA. Penn Capital Management Company LLC acquired a new stake in shares of Biomerica in the first quarter valued at about $50,000. Jane Street Group LLC acquired a new stake in shares of Biomerica in the first quarter valued at about $57,000. Fore Capital LLC grew its stake in shares of Biomerica by 67.4% in the first quarter. Fore Capital LLC now owns 49,680 shares of the company’s stock valued at $93,000 after buying an additional 20,000 shares in the last quarter. Perritt Capital Management Inc. boosted its holdings in Biomerica by 170.0% in the first quarter. Perritt Capital Management Inc. now owns 67,500 shares of the company’s stock valued at $126,000 after purchasing an additional 42,500 shares during the last quarter. Finally, MYDA Advisors LLC purchased a new position in Biomerica in the first quarter valued at about $138,000. Institutional investors and hedge funds own 28.08% of the company’s stock.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.